<DOC>
	<DOCNO>NCT00099710</DOCNO>
	<brief_summary>The purpose study examine safety tolerability curcumin , determine effect patient mild moderate Alzheimer 's Disease ( AD ) .</brief_summary>
	<brief_title>Curcumin Patients With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description>Curcumin , yellow substance find spice Turmeric , antioxidant , non-steroidal anti-inflammatory ( NSAID ) , cholesterol-lowering property , make good candidate prevention treatment AD . The study examine safety tolerability 2 different dos curcumin C3 complex . Blood cerebrospinal fluid ( CSF ) test use examine curcumin absorb body , whether effect inflammation , oxidative damage , cholesterol level . Participants also test determine potential effect curcumin cognition , behavior , daily function patient mild moderate AD . Participants randomly assign receive one two dos curcumin , placebo , initial 6 month trial . For final 6 month , receive placebo switch one two dos drug . The 33 participant make 7 visit study site 12-month period . These visit may include physical neurological examination , routine laboratory test , lumbar puncture , neuropsychological ( mood memory ) evaluation .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Male female least 50 year old Diagnosis probable AD No history significant psychiatric nonAD neurological disease Proficient English able perform cognitive test Caregiver available monitor administer medication accompany patient every clinical visit On stable dos cholinesterase inhibitor memantine ( Alzheimer 's medication ) 3 month prior enrollment On stable dos allow medication least one month prior start study medication Current recent major psychiatric illness ( i.e . bipolar disorder , schizophrenia ) Significant , uncontrolled systemic illness ( i.e . chronic renal failure , chronic liver disease , poorly control diabetes , poorly control congestive heart failure ) Recent history gastrointestinal bleeding ulceration Alcoholism substance abuse within past year Familial , autosomal dominant Alzheimer 's disease due mutation know gene ( Presenilin1 , Presenilin2 , Amyloid Precursor Protein ) NSAIDs ( e.g . ibuprofen , naproxen , etc . ) take regular basis ( 3 time per week ) Aspirin dose 325 mg per day Coumadin , heparin , anticoagulant Antioxidants supplement include gingko biloba , coenzyme Q10 , alphalipoic acid Vitamin E dose 2,000 IU per day Vitamin C dose 500 mg per day</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Curcumin</keyword>
	<keyword>Turmeric</keyword>
	<keyword>Curry</keyword>
	<keyword>NSAID</keyword>
	<keyword>anti-inflammatory</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>anti-oxidant</keyword>
</DOC>